Helen Giamarellou (H Giamarellou)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Combination Therapy

Klebsiella Pneumoniae

Cystic Fibrosis

Top Venues

The Journal of antimicrobial chemotherapy

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Expert review of anti-infective therapy

Expert opinion on drug metabolism & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Irene Galani, Maria Souli, D Katsala, Ilias Karaiskos, Helen Giamarellou, Anastasia Antoniadou
In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Irene Galani, Vassiliki Papoutsaki, Ilias Karaiskos, Nikolaos Moustakas, Lamprini Galani, Sofia Maraki, Viktoria Eirini Mavromanolaki, Olga Legga, Kimon Fountoulis, Evangelia D Platsouka, Panagiota Giannopoulou, Helen Papadogeorgaki, Maria Damala, Efrosini Chinou, Aggeliki Pasxali, Ioannis Deliolanis, Helen Vagiakou, Efthymia Petinaki, Anastasia Chli, Eleni Vagdatli, Polyzo Kazila, Vassiliki Papaioannou, Konstantina Kontopoulou, Atalia Noemi Ferke, Eleni Moraitou, Anastasia Antoniadou, Helen Giamarellou
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Irene Galani, Vassiliki Papoutsaki, Ilias Karaiskos, Nikolaos Moustakas, Lamprini Galani, Sofia Maraki, Viktoria Eirini Mavromanolaki, Olga Legga, Kimon Fountoulis, Evangelia D Platsouka, Panagiota Giannopoulou, Helen Papadogeorgaki, Maria Damala, Efrosini Chinou, Aggeliki Pasxali, Ioannis Deliolanis, Helen Vagiakou, Efthymia Petinaki, Anastasia Chli, Eleni Vagdatli, Polyzo Kazila, Vassiliki Papaioannou, Konstantina Kontopoulou, Atalia Noemi Ferke, Eleni Moraitou, Anastasia Antoniadou, Helen Giamarellou
In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Irene Galani, Ilias Karaiskos, Helen Giamarellou
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations. Expert review of anti-infective therapy 19 (11) (2021)
Ilias Karaiskos, Irene Galani, Vassiliki Papoutsaki, Lamprini Galani, Helen Giamarellou
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies. Expert review of anti-infective therapy (2021)
Irene Galani, Ilias Karaiskos, Evdokia Angelidis, Vassiliki Papoutsaki, Lamprini Galani, Maria Souli, Anastasia Antoniadou, Helen Giamarellou
Emergence of ceftazidime-avibactam resistance through distinct genomic adaptations in KPC-2-producing Klebsiella pneumoniae of sequence type 39 during treatment. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 40 (1) (2020)
Ilias Karaiskos, Irene Galani, Maria Souli, Helen Giamarellou
Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens. Expert opinion on drug metabolism & toxicology 15 (2) (2019)
Ilias Karaiskos, Anastasia Antoniadou, Helen Giamarellou
Combination therapy for extensively-drug resistant gram-negative bacteria. Expert review of anti-infective therapy 15 (12) (2017)